31 Mar 2019
Assets256.56
Total Income102.07
Profit After Tax3.98
NET Worth55.60
Total Borrowing164.57
Open 26th Jul 2023 · Close 28th Jul 2023 · Listing 7th Aug 2023
The shares listed at ₹306.10, a 2.03% move from the issue price. Yatharth Hospital is a Mainboard IPO with an issue size of ₹686.55 crore, proposed for listing on BSE, NSE. The offer opens on 26th Jul 2023 and closes on 28th Jul 2023. The issue structure includes a fresh issue of ₹490.00 crore and an offer-for-sale component of ₹196.55 crore. The current listing schedule points to 7th Aug 2023.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 50 | ₹15,000 |
| Object | Amount |
|---|---|
| Repayment/ prepayment, in full or part, of certain borrowings availed by the Company. | ₹100.00 Cr |
| Repayment/ prepayment, in full or part, of certain borrowings availed by our Subsidiaries, namely, AKS Medical & Research Centre Private Limited (“AKS”) and Ramraja Multispeciality Hospital & Trauma Centre Private Limited (“Ramraja”) | ₹145.00 Cr |
| Funding capital expenditure expenses of our Company for two hospitals, namely, Noida Hospital and Greater Noida Hospital. | ₹25.64 Cr |
| Funding capital expenditure expenses of our Subsidiaries, AKS and Ramraja, for respective hospital operated by them. | ₹106.97 Cr |
| Funding inorganic growth initiatives through acquisitions and other strategic initiatives | ₹65.00 Cr |
| General corporate purposes. | ₹127.10 Cr |
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
| Expense | Amount |
|---|---|
| BRLMs’ fees and commissions (including underwriting commission, brokerage and selling commission) | ₹28.08 Cr |
| Commission/processing fee for SCSBs, Sponsor Banks and Bankers to the Offer. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹4.71 Cr |
| Fees payable to the Registrar to the Offer | ₹0.26 Cr |
| Others (i) Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses. (ii) Printing and stationery expenses (iii) Advertising and marketing expenses (iv) Fees payable to other advisors to the Offer such as Statutory Auditor for preparing the Restated Consolidated Financial Information, statement of possible special tax benefits and for furnishing confirmations and certificates for purposes of the Offer and legal counsels for drafting of Offer related documentation and assisting the BRLMs in conducting due diligence, etc. (v) Miscellaneous | ₹20.60 Cr |